ASX announcements

25 May 2022

Shareholders should take no action in respect of revised BGH offer until you receive further information

16 May 2022

Virtus’ Second Supplementary Target’s Statement (BGH Offer)

16 May 2022

Virtus’ First Supplementary Target’s Statement (CapVest Offer)

13 May 2022

Virtus Health provides a FY22 April Year to Date Trading Update

11 May 2022

Virtus’ First Supplementary Target’s Statement

6 May 2022

Letters to shareholders to access CapVest Transaction Booklet

6 May 2022

Letters to shareholders to access Target Statement in response to BGH Offer

5 May 2022

Virtus releases CapVest Transaction Booklet

5 May 2022

Court orders convening of capvest scheme meeting and approves distribution of transaction booklet

3 May 2022

Virtus' Target's Statement recommends reject the BGH offer

22 April 2022

Update from Chair of Virtus Health: Proposals from CapVest and BGH Capital

14 April 2022

Virtus signs revised Transaction Implementation Deed

11 April 2022

Virtus receives an improved proposal from CapVest

6 April 2022

Virtus Board to consider Takeover offer by BGH

4 April 2022

Letter to Shareholders updating on CapVest Scheme and Takeover

25 March 2022

Foreign Investment Review Board approval received for CapVest transaction

14 March 2022

Virtus enters into binding implementation deed with CapVest at improved price following receipt of updated non-binding, conditional indication of interest f

1 March 2022

Virtus Health announces that CapVest tables improved proposal to acquire Virtus

28 February 2022

Virtus Health received a revised nonbinding conditional indication of interest from BGH Capital Pty Ltd

24 February 2022

Virtus Health refers to the decision and final orders of the Takeovers Panel in response to the application dated 2 February 2022